None listed
Conditions
Brief summary
Diet and nutrition are considered important in the prevention, development, and management of IBD. Given the importance of diet in IBD, patients are often keen to explore dietary strategies to manage the condition, however the uptake of diet as a treatment option is inconsistent. Dietary education may lead to improved dietary intake and consequent better nutritional status and well-being. This study aims to show whether a focused dietary education intervention is beneficial for children with CD. Key targets are increased fibre intake and improved well-being.
Interventions
The study design and population
This will be a prospective, unblinded intervention study, involving 30 children with known CD, who receive care at the Christchurch Public Hospital Paediatric IBD clinic in Canterbury, New Zealand.
The interventions
There will be two intervention materials for the study: a summary booklet and a pre-recorded webinar video. Both materials will contain the same information. An A5 booklet of 17 pages, requiring approximately 7-10 minutes to read will be given to eac
The study design and population This will be a prospective, unblinded intervention study, involving 30 children with known CD, who receive care at the Christchurch Public Hospital Paediatric IBD clinic in Canterbury, New Zealand. The interventions There will be two intervention materials for the study: a summary booklet and a pre-recorded webinar video. Both materials will contain the same information. An A5 booklet of 17 pages, requiring approximately 7-10 minutes to read will be given to each participant. The booklet will be based on information focusing on fibre-rich diets, extracted from the NZ Food and Nutrition Guidelines for Healthy Children and Young People. The booklet will have three sections: Section one will introduce what fibre is and the common types of dietary fibres. Section two will discuss the roles of fibres in the human body, how to add fibre to the diet, and the daily recommended fibre intake. Section three will highlight the amount of fibres present in a serving portion of common fibre types and important tips for fibre intake during remission. The information in the booklet will be transformed into a PowerPoint show and recorded as a video with a Paediatric Gastroenterology Dietitian providing additional information as a voice-over as the slides progress. Intervention delivery The study participants will receive the summarised intervention booklet at baseline. Participants will be invited to attend only one session of the pre-recorded webinar throughout the intervention period. The webinar will be split into three segments following the same guidelines and administered immediately after baseline data collection. Each segment will run for approximately 3 minutes, and the entire webinar for approximately 10 minutes. The webinars will be viewed at home. Children younger than 15 years will view the webinars at together with their parents/guardians, while those 16-17 years may attend the session independently. The webinar videos will be uploaded to Qualtrics to enable participants to view the content of the three segments multiple times as they wish (booster sessions). The booster sessions aim to reinforce the progress achieved from previous views and help the investigator track participants’ access to the content. Reminder emails or short message service (SMS) will be sent to participants who have not watched all the segments. A study email address will be provided for participants to send concerns or ask questions for clarification.
Sponsors
University of Otago
Study design
Allocation
Non-randomised trial
Primary purpose
Prevention
Eligibility
Sex/Gender
All
Age
6 Years to 17 Years
Healthy volunteers
No
Inclusion criteria
Children will be included if they have CD, are aged 6-17 years, on a stable dose(s) of medication for at least four weeks and have quiescent or mild disease activity defined as a Paediatric Crohn’s Disease Activity Index (PCDAI) -1 to < +1SD by the World Health Organisation (WHO) BMI z-score indices for ages 2-19 years, and taking partial enteral nutrition (PEN) will also be eligible.
Exclusion criteria
Children with moderate or severe disease activity (i.e., PCDAI score equal to or greater than 30) will be excluded. Children on a reducing dose of corticosteroids or who have started a new medication in the last 4 weeks will also be ineligible. Children with a ‘moderate’ or ‘severe’ nutritional risk, defined as <-2 SD or <-3 SD by the WHO BMI z-score indices for children of this age, will be left out. Those on regular or occasional prebiotic, probiotic or symbiotic supplements or on restricted diets for the preceding month will be ineligible.
Outcome results
None listed